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INTRODUCTION
New technologies and the increasing presence of Internet-connected computer systems in every
aspect of our lives (e.g., during work, free time, or times dealing with health issues) have
made a large amount of information available about human behavior (Barsocchi et al., 2015;
Watanabe et al., 2017). This information is systematically stored in database systems. For
example, administrative databases contain much information about health-related behaviors and
are constantly updated so that every time someone receives a drug by a physician’s prescription,
that information is recorded in the database (Parri et al., 2015; Giusti et al., 2016, 2017; Giudici et al.,
2017; Cianferotti et al., 2018). In this regard, a relevant topic for many psychological applications
is switching behaviors: data which describe the shift from a certain behavior or situation to the
same or another behavior or situation. The phrase behavior or situation refers to a variety of health
conditions and behaviors (e.g., dietary habits); in this paper, I will consider drug consumption: a
type of critical health-related information which can be retrieved from administrative databases.
The prescription of a given drug, for example, and the subsequent prescription of the same
or another drug (i.e., no switch compared to switch) may be found in a database. From a
methodological point of view, however switching behavior has been usually analyzed by aggregating
data in order to compare a group of individuals who have switched in a given period of time to
a group of individuals who have not switched during the same period (Ganguli, 2002; Thiebaud
et al., 2005; Ideguchi et al., 2008). On one hand, given the complexity of large databases containing
drug prescriptions of tens of thousands of people for several years, it is necessary to simplify and
adopt some strategy to analyze them in a manageable way. On the other hand, this approach
does not allow us to exploit the actual structure of drug-switching behaviors (e.g., answering
questions such as “Given a certain drug, what are the other drugs with which a switch is more
likely?”). The aim of this paper is to show how graph theory (Kolaczyk and Csárdi, 2014; Luke,
2015) could be employed to model and improve the analysis of switching behavior; indeed, the
availability of database information and the potential for a mathematical modeling approach such
as network theory—which is still not widely used with this aim—could greatly improve the analysis
of switching behavior (in other fields—for example, marketing research—a similar approach has
been already proposed, see Iacobucci et al., 1996). The paper is organized as follows: first, it will
describe why an improvement in data analysis approaches for investigating adherence and, in
particular, switching behaviors is important for the field of psychology. Then, discussion of the
benefits of adopting network analysis compared to traditional analysis will follow.
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THE NEED IN PSYCHOLOGY FOR DEEPER
INVESTIGATION OF ADHERENCE AND
SWITCHING BEHAVIORS
When a physician gives a patient instructions about a healthcare
program (e.g., prescriptions, dietary habits, and physical
activities), the patient may or may not follow medical advice.
Adherence (also called compliance) measures the degree to
which a patient correctly follows the physician’s directions,
whereas persistence refers to taking the treatment for the
prescribed duration. From a psychological point of view, this
set of complex behaviors involves many variables (e.g., habits,
motivation, intentions, and beliefs). Within health psychology
several theoretical models have been proposed to design behavior
change interventions. Michie et al. (2011) wrote:
“Behavior change interventions can be defined as coordinated
sets of activities designed to change specified behavior patterns.
In general, these behavior patterns are measured in terms of
the prevalence or incidence of particular behaviors in specified
populations (e.g., delivery of smoking cessation advice by general
practitioners). Interventions are used to promote uptake and
optimal use of effective clinical services, and to promote healthy
lifestyles.” (p. 1).
More recently, within thinking psychology, the dual process
theory of thought (Sloman, 1996) has been exploited to achieve
those goals. According to this theory, thought is the result of
two forms of thinking: (a) a slow, effortful, deliberative process
and (b) a fast, effortless, default- and associative-based process.
Exploiting the properties of the latter form of reasoning, the
Nudge framework proposed by Thaler and Sunstein (2009)
suggests interventions on the architecture of choice using defaults
and indirect suggestions to obtain nonforced compliance and to
influence the motives and decision-making processes of people.
Such “cognitive-based” interventions can be very effective in
promoting positive behaviors and increasing the acceptance of
physicians’ suggestions (Pampaloni et al., 2015).
Accessibility to administrative databases (Parri et al., 2015;
Giusti et al., 2016, 2017; Cianferotti et al., 2018) allows for the
possibility of systematically measuring health-related behavior,
thus making it possible to ascertain if patients have a sufficiently
high adherence to prescribed drugs (Cianferotti et al., 2015,
2017; Vannucci et al., 2017a,b). In the case of low compliance,
it is desirable to conduct some type of intervention (e.g., classic
behavior change intervention or Nudge-based), and thus it would
be necessary to monitor the effectiveness of the intervention by
analyzing the administrative database.
Drug-switching behavior represents a crucial topic in this
regard. In some cases, the physician may ask a patient to
switch their medication. In order to increase bone mass, for
example, bisphosphonates may be used as a treatment option;
in current medical practice patients might be given two or
more bisphosphonate drugs in sequence (Ideguchi et al., 2008).
Administrative database records provide information about
drugs actually taken in the pharmacies, so it is possible to
acquire data about how prescriptions of various drugs change in
sequence. Such analyses may help to answer important questions
like “Do patients switch drugs in the way prescribed by the
physician?”; “What switch pattern is associated with the best
clinical outcome (e.g., reduction in probability of fracture)?”;
and “Do the educational interventions succeed in promoting the
desired switch pattern of drugs?”
Another example f drug-switching behavior relates to generic
and branded drugs. The physician may prescribe a drug, and
when the patient goes to the pharmacy, the patient can choose
(according to advice from the pharmacy clerk) to take either
the branded or generic drug. In certain cases, however, the two
versions of the drug may differ in terms of efficacy or tolerability
(Andermann et al., 2007; Kesselheim et al., 2008). Patients with
chronic disease may take their drugs for a long time, switching
continuously from branded drugs to generic ones. Again, the
pattern of switching behavior can be related to clinical outcomes
(i.e., health-related variables, such as the probability of fracture
or mortality).
GOING BEYOND TRADITIONAL ANALYSIS:
THE ADVANTAGES OF USING NETWORK
THEORY
A researcher who is interested in investigating the topics
described in the previous section may obtain data from
administrative databases. Information is usually organized in
rows containing, on the columns, the following terms about each
prescription: (a) the date when the drug was dispensed, (b) the ID
of the patient to whom the drug was prescribed, (c) the typology
of drug, and (d) other variables. By sorting the data by date,
patient ID, and typology, it is possible to know if a patient, in
a given interval of time, has switched drugs (or classes of drugs).
Alternatively, it is possible to compute how many times a patient
has switched.
Traditional analyses are usually limited to the comparison
between a group of patients who have not switched drugs versus
a group of patients who have switched drugs in a given interval of
time (Saag et al., 2002; Ideguchi et al., 2008; Martin et al., 2009).
For example, switch versus no switch patients can be compared in
terms of commonly employed adherence measures (e.g., medical
possession ratio [MPR]). These methods are usually adequate to
handle databases with only a few different types of drugs, and they
have the advantage of simplicity; however, the main disadvantage
is that analyses of databases with these traditional methods can
miss the actual complexity of switching behavior, especially when
using several different drugs and very large databases. Indeed,
with a database of acceptable size, it is possible to construct
a matrix reporting the different drugs in rows and columns
and the frequency of switches in each cell, and this adjacency
matrix is amenable to being analyzed in terms of network theory
(Gronchi et al., 2013, 2014; Kolaczyk and Csárdi, 2014; Luke,
2015). Graph theory, in turn, can provide several indices for
going beyond traditional approaches. Following this idea, each
drug is considered as a node in a graph, and the (possible) switch
is viewed as an edge. Among the simplest indices that can be
computed on the adjacency matrix is degree centrality (i.e., the
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number of links incident upon a node). This will allow answers to
questions such as “Howmany different drugs are switched to that
particular drug?” Closeness centrality can also be useful: It allows
measurement of the degree to which a drug is “near,” in terms of
switch, to all other drugs in a network. This index computes the
shortest paths between all nodes (in our case, drugs), and then it
assigns to each node a score based on its sum of shortest paths.
Closeness centrality can thereby help to find a drug to which all
the other drugs tend to shift with a few number of switches.
In clinical situations where several types drugs are
administered (e.g., osteoporosis research; Ideguchi et al.,
2008) or where large databases are used, drug switches may
interact in a complex way, forming structured patterns. In
this case, network analysis has made available many clustering
algorithms (Sales-Pardo et al., 2007; Rosvall and Bergstrom,
2008; Lancichinetti et al., 2011; Gronchi et al., 2013, 2014). By
using those algorithms, it is possible to detect how the different
switch patterns of drugs form distinct groups. For example,
drugs A, B, and C might usually form a cluster (i.e., a set of drugs
that usually switch from one to another of the same group),
whereas drugs D, E, and F might form a different cluster.
There are some limitations in the use of network theory
for analyzing drug-switching behavior. First, gaining the
official permissions to access administrative databases at single-
prescription and single-patient levels is not easy; even if the IDs
are anonymous, these data are sensitive information and they
are usually only available to the researcher in aggregate form.
This access, however, is necessary to construct the adjacency
matrix. Moreover, in order to apply network theory, databases
must be large and related to several drugs in order to have a
structured adjacency matrix with enough rows and columns.
Only in particular clinical contexts, however, is it meaningful to
investigate the switch among several drugs because it is necessary
to employ network theory.
CONCLUSION
This paper advocates for the use of network theory, which can
be used to more precisely compare matrices of drug-switching
information obtained from different samples (e.g., control versus
intervention groups), thus going beyond the simple probability of
switch. Systematic and meta-analytic reviews (Borenstein et al.,
2009; Tallandini et al., 2014, 2016) regarding drug-switching
behavior are necessary for evaluating the feasibility of the use
of network theory in this respect. Its expanded use for analyzing
switching behavior may allow for better investigations of health-
related behavior (e.g., the measure of compliance with physicians’
indications) and the efficacy of educational and cognitive-based
interventions for enhancing adherence.
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